2014
DOI: 10.1373/clinchem.2013.220392
|View full text |Cite
|
Sign up to set email alerts
|

Mass Spectrometry–Based Candidate Reference Measurement Procedure for Quantification of Amyloid-β in Cerebrospinal Fluid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
98
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

7
1

Authors

Journals

citations
Cited by 138 publications
(106 citation statements)
references
References 22 publications
(15 reference statements)
3
98
0
1
Order By: Relevance
“…If the methods give correlating results, the use of a commutable CRM for calibration should make it possible to produce values that are comparable irrespective of analytical method, time or place of measurement [32]. In the present study, it was shown that the majority of the results of the different immunoassays correlate well; and in addition, they also correlate with results from the SRM-based method, which has now been published as candidate SRM-based RMP [27,33]. The first substudy confirmed that the majority of methods tested were highly correlated (R 2 > 0.9) as shown previously [19].…”
Section: Discussionmentioning
confidence: 49%
See 1 more Smart Citation
“…If the methods give correlating results, the use of a commutable CRM for calibration should make it possible to produce values that are comparable irrespective of analytical method, time or place of measurement [32]. In the present study, it was shown that the majority of the results of the different immunoassays correlate well; and in addition, they also correlate with results from the SRM-based method, which has now been published as candidate SRM-based RMP [27,33]. The first substudy confirmed that the majority of methods tested were highly correlated (R 2 > 0.9) as shown previously [19].…”
Section: Discussionmentioning
confidence: 49%
“…Duplicate samples 300 ng/L, 800 ng/L, and 1300 ng/L. The SRM method was performed on a triple quadrupole MS as previously described [26], except that calibration was performed using the surrogate analyte approach [27]. All CSF samples were left-over samples from the clinical routine at the Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.…”
Section: Materials and Measurement Procedures Commutability I And Iimentioning
confidence: 99%
“…2A) and CHO-7PA2-APP751 (Fig. 2B) using LC-MS/MS [34,35]. Like Aftins [13,14], triazines induced a reduction in Aβ 38 levels, a slight increase or modest decrease in Aβ 40 levels and a strong increase in Aβ 42 levels (Fig.…”
Section: Mass Spectrometric Quantification and Profile Analysis Of Inmentioning
confidence: 99%
“…Solid phase extraction, liquid chromatography (LC) and MS/MS analysis of Aβ species was performed as described previously [34,35] peptides (rPeptide) were added to a final concentration of 1.6 ng/mL in calibrators and unknown samples as internal standards. Standard curves were constructed using the unlabeled to 15 N-Aβ peak area ratios and fitted using linear regression.…”
Section: Supplementary Informationmentioning
confidence: 99%
“…Production of candidate CRMs for Aβ 42 is an ongoing work with the efforts from the IFCC working group on CSF proteins [49] and from the BIOMARKAPAD consortium. Thereby, two candidate RMPs for quantification of Aβ 42 [50,51] and one for quantification of t-Tau [52] were recently reported.…”
Section: Variability Linked To Kit Providersmentioning
confidence: 99%